The Future of theAcne Vulgaris Market: Growth Trends, Market Size, and Opportunities to Watch
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theAcquired Immunodeficiency Syndrome (AIDS) Market from 2025 to 2034?
The increasing prevalence of HIV infections is expected to contribute to the expansion of the acquired immunodeficiency syndrome (AIDS) market. HIV infections occur due to the human immunodeficiency virus (HIV), which weakens the immune system, reducing the body’s ability to fight infections and diseases. The rise in HIV cases is linked to factors such as unprotected sexual contact with infected individuals, sharing needles, receiving contaminated blood products, having multiple sexual partners, and pre-existing sexually transmitted infections. Managing acquired immunodeficiency syndrome (AIDS) involves early diagnosis, broader access to effective antiretroviral therapies, improved prevention strategies, and strengthened healthcare systems, all of which help control the virus’s spread. For example, in November 2024, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based European Union agency, reported 112,883 HIV diagnoses in 2023 across 47 out of 53 countries in the region, with 24,731 cases recorded in the European Union/European Economic Area (EU/EEA). The overall HIV diagnosis rate rose to 12.7 per 100,000 people, marking a 2.4% increase from the 12.4 per 100,000 reported in 2022. Therefore, the growing number of HIV infections is driving the acquired immunodeficiency syndrome (AIDS) market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21076&type=smp
How Will the Growth Rate of theAcquired Immunodeficiency Syndrome (AIDS) Market Impact Industry Trends by 2034?
The acquired immunodeficiency syndrome (AIDS) market has also grown substantially in recent years. It is expected to increase from $32.09 billion in 2024 to $33.85 billion in 2025, with a CAGR of 5.5%. This growth in the past can be attributed to rising HIV infection rates, increased government funding for HIV treatment, the expansion of global awareness programs, advancements in diagnostic capabilities, and greater support from non-governmental organizations.
The acquired immunodeficiency syndrome (AIDS) market size is forecasted to grow significantly over the next few years. By 2029, it is set to reach $41.57 billion, with a compound annual growth rate (CAGR) of 5.3%. The projected growth is attributed to the increasing demand for long-acting injectable therapies, the growing adoption of pre-exposure prophylaxis (PrEP), rising investments in HIV cure research, the expansion of telemedicine services for HIV care, a heightened focus on personalized medicine, and greater awareness regarding early HIV diagnosis. Notable trends expected during this period include a shift toward single-tablet regimens, increasing preference for injectable and implantable HIV treatments, a growing demand for digital health solutions in HIV management, a rising interest in functional HIV cure strategies, and an expanding role of artificial intelligence in drug discovery.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21076
How Are Market Trends and Innovations Revolutionizing theAcquired Immunodeficiency Syndrome (AIDS) Industry in Recent Times?
In the acquired immunodeficiency syndrome (AIDS) market, companies are emphasizing long-acting injectables to improve patient compliance, reduce dosing frequency, and offer a more convenient alternative to daily oral antiretroviral treatments. For instance, in January 2025, GSK plc., a UK-based pharmaceutical company, announced European Commission approval for its long-acting injectable regimen of Vocabria (cabotegravir) plus Rekambys (rilpivirine) for adolescents living with HIV. Administered once every one or two months, this treatment improves adherence rates, especially among those who struggle with daily pill regimens.
Which Key Market Players Are Shaping the Future and Growth of theAcquired Immunodeficiency Syndrome (AIDS) Market?
Major companies operating in the acquired immunodeficiency syndrome (AIDS) market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi SA, Bristol-Myers Squibb Company, Abbott, GSK plc, Takeda Pharmaceuticals, Gilead Sciences, Viatris Inc., Teva Pharmaceuticals, Aurobindo Pharma, Cipla Ltd, Shionogi and Co., Dr. Reddy’s Laboratories, Lupin, Hetero Drugs Limited, Glenmark Pharmaceuticals Limited, ViiV Healthcare
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Acquired Immunodeficiency Syndrome (AIDS) Market, and How Do They Contribute to Growth?
The acquired immunodeficiency syndrome (AIDS) market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus 1, Human Immunodeficiency Virus 2
2) By Drug Type: Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Fusion Inhibitors, CCR5 Anatagonists And Post-Attachment Inhibitors, Protease Inhibitors, Integrase Inhibitors, Pre-Exposure Prophylaxis And Post-Exposure Prophylaxis
3) By Route Of Administration: Oral, Parenteral
4) By Application: Hospital Pharmacy, Retail Pharmacy, Other Applications
5) By Distribution Channel: Offline, Online
Subsegments:
1) By Human Immunodeficiency Virus 1 (HIV-1): Antiretroviral Therapy (ART), Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), HIV-1 Diagnostic Tests, HIV-1 Vaccine Development, HIV-1 Opportunistic Infection Management
2) By Human Immunodeficiency Virus 2 (HIV-2): Antiretroviral Therapy (ART) For HIV-2, HIV-2 Diagnostic Tests, HIV-2 Surveillance And Epidemiology, HIV-2 Vaccine Research, Management Of HIV-2 Co-Infections
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21076&type=smp
What Regions Are Dominating the Acquired Immunodeficiency Syndrome (AIDS) Market Growth?
North America was the largest region in the acquired immunodeficiency syndrome (AIDS) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acquired immunodeficiency syndrome (AIDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Acquired Immunodeficiency Syndrome (AIDS) Market 2025, By The Business Research Company:
Pneumococcal Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report
Vaccine Contract Manufacturing Global Market Report 2025
Cold Pain Therapy Global Market Report 2025
https://thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
